Production (Stage)
Compass Therapeutics, Inc.
CMPX
$2.41
$0.000.00%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
2/4/2025
-
MarketBeat
6/15/2025
-
MarketBeat
6/13/2025
-
The Fly
6/12/2025
-
Simply Wall St
6/9/2025
-
The Fly
5/29/2025
-
MarketBeat
5/29/2025
-
Ticker Report
5/29/2025
-
Ticker Report
5/28/2025
-
GuruFocus
5/28/2025
-
Globe Newswire
5/27/2025
-
GuruFocus
5/27/2025
-
ETF Channel
5/24/2025
-
MarketBeat
5/20/2025
-
MarketBeat
5/16/2025
-
MarketBeat
5/14/2025
-
Ticker Report
5/14/2025
-
MarketBeat
5/14/2025
-
MarketBeat
5/13/2025
-
MarketBeat
5/13/2025
-
SeekingAlpha
5/13/2025
-
Seeking Alpha - Long Ideas
5/11/2025
-
Ticker Report
5/9/2025
-
GuruFocus
5/9/2025
-
GuruFocus
5/9/2025
-
The Fly
Income Statement
Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Thursday, May 8, 2025
Period Date
Monday, March 31, 2025
Next Filing
Week of Aug 11 and 15 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
--
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
617 500 8099
Address
80 Guest Street
Boston, MA 02135
Boston, MA 02135
Country
Year Founded
Business Description
Sector
Compass Therapeutics, Inc., a clinical-stage oncology-focused biopharmaceutical company, engages in the development of antibody-based therapeutics for the treatment of various human diseases in...
more